The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market.
According MarketsandMarkets, a new market research report – [164 Pages Report] The lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890
The market is segmented based on the type, material, product, end user, and region. Based on the type, the tracheobronchial segment accounted for the largest share of the airway stent/lung stent market in 2018. The large share of this segment can be attributed to the higher adoption trends seen in the tracheal and bronchial stents for use in the treatments of respiratory disorders.
Based on material, the airway stent/lung stent market is divided into metal, silicone, and hybrid stents. In 2018, metal stents accounted for the largest share in the airway stent/lung stent market. The advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment.
By product, the airway stent/lung stent market is segmented into expandable and non-expandable stents. The expandable stents segment is expected to hold the largest share in 2019. The large share of this segment can be attributed to the higher preference of these stents by surgeons owing to advantages such as easy insertion in bronchoscopy procedures, lower risks of stent-induced complications, and small size.
Geographically, the global airway stent/lung stent market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold the largest share of this market in 2019. The dominant share of North America can mainly be attributed to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and rising healthcare expenditure.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890
The major players operating in the airway stent/lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.